Variant report

Variant	rs7175354
Chromosome Location	chr15:31316080-31316081
allele	C/G
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

No.	Transcrition factor	Chromosome Location	Cell Line	Cell type	Cell Stage	Matched TF binding sites
1	FOS	chr15:31315998-31316950	HUVEC	blood vessel:	n/a	chr15:31316631-31316641 chr15:31316248-31316256 chr15:31316248-31316256 chr15:31316628-31316639 chr15:31316630-31316641 chr15:31316630-31316642 chr15:31316249-31316256 chr15:31316632-31316640 chr15:31316247-31316257
2	FOS	chr15:31315983-31316830	MCF10A-Er-Src	breast:	n/a	chr15:31316631-31316641 chr15:31316248-31316256 chr15:31316248-31316256 chr15:31316628-31316639 chr15:31316630-31316641 chr15:31316630-31316642 chr15:31316249-31316256 chr15:31316632-31316640 chr15:31316247-31316257
3	JUN	chr15:31316074-31317022	HUVEC	blood vessel:	n/a	chr15:31316631-31316641 chr15:31316248-31316256 chr15:31316248-31316256 chr15:31316628-31316639 chr15:31316630-31316642 chr15:31316249-31316256 chr15:31316632-31316640 chr15:31316247-31316257
4	FOS	chr15:31316065-31316811	MCF10A-Er-Src	breast:	n/a	chr15:31316631-31316641 chr15:31316248-31316256 chr15:31316248-31316256 chr15:31316628-31316639 chr15:31316630-31316641 chr15:31316630-31316642 chr15:31316249-31316256 chr15:31316632-31316640 chr15:31316247-31316257
5	FOS	chr15:31316043-31316859	MCF10A-Er-Src	breast:	n/a	chr15:31316631-31316641 chr15:31316248-31316256 chr15:31316248-31316256 chr15:31316628-31316639 chr15:31316630-31316641 chr15:31316630-31316642 chr15:31316249-31316256 chr15:31316632-31316640 chr15:31316247-31316257

Variant related genes	Relation type
ENSG00000259720	TF binding region

Extended variants
information (count: 35 )
Associated
traits (count: 0)

rSNPs within LD-proxies of this variant (count:22)

rs_ID	r²[population]
rs10519726	0.83[CEU][hapmap];0.90[CHB][hapmap];1.00[JPT][hapmap];0.89[ASN][1000 genomes]
rs12437677	0.91[ASN][1000 genomes]
rs12441456	0.89[ASN][1000 genomes]
rs12442021	0.87[ASN][1000 genomes]
rs12442333	0.90[CHB][hapmap];1.00[JPT][hapmap];0.89[ASN][1000 genomes]
rs12442823	0.91[ASN][1000 genomes]
rs16956341	0.90[CHB][hapmap];1.00[JPT][hapmap]
rs16956362	0.90[CHB][hapmap];1.00[JPT][hapmap]
rs16956366	0.91[CHB][hapmap];1.00[JPT][hapmap]
rs16956414	0.90[CHB][hapmap];1.00[JPT][hapmap];0.87[ASN][1000 genomes]
rs16956422	0.90[CHB][hapmap];1.00[JPT][hapmap];0.85[ASN][1000 genomes]
rs16956460	0.93[ASN][1000 genomes]
rs28487996	0.96[ASN][1000 genomes]
rs36042462	0.89[ASN][1000 genomes]
rs3743232	0.91[ASN][1000 genomes]
rs3784588	0.90[CHB][hapmap];1.00[JPT][hapmap];0.91[ASN][1000 genomes]
rs6493358	0.91[CHB][hapmap];1.00[JPT][hapmap];0.83[ASN][1000 genomes]
rs7164939	0.91[CHB][hapmap]
rs73368444	0.89[ASN][1000 genomes]
rs871312	0.90[CHB][hapmap]
rs872843	0.91[CHB][hapmap];1.00[JPT][hapmap];0.87[ASN][1000 genomes]
rs964925	0.81[CHB][hapmap]

Variant overlapped rSNPs/rCNVs (count:13 , 50 per page) page: 1

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	nsv531138	chr15:30653877-31609679	Active TSS Weak transcription Enhancers Strong transcription Flanking Active TSS Transcr. at gene 5' and 3' Genic enhancers Flanking Bivalent TSS/Enh ZNF genes & repeats Bivalent Enhancer Bivalent/Poised TSS	TF binding region CpG island Chromatin interactive region lncRNA miRNA miRNA target site	96 gene(s)	inside rSNPs	diseases
2	nsv916936	chr15:30921917-31337510	Active TSS Weak transcription Strong transcription Enhancers Bivalent/Poised TSS Genic enhancers Flanking Active TSS ZNF genes & repeats Transcr. at gene 5' and 3' Bivalent Enhancer Flanking Bivalent TSS/Enh	TF binding region CpG island Chromatin interactive region lncRNA miRNA target site	37 gene(s)	inside rSNPs	diseases
3	nsv525795	chr15:30936285-31324531	Weak transcription Enhancers ZNF genes & repeats Strong transcription Active TSS Genic enhancers Flanking Active TSS Transcr. at gene 5' and 3' Bivalent Enhancer Bivalent/Poised TSS Flanking Bivalent TSS/Enh	TF binding region CpG island Chromatin interactive region lncRNA miRNA target site	35 gene(s)	inside rSNPs	diseases
4	nsv903831	chr15:30986051-31723279	Flanking Active TSS Enhancers Active TSS Weak transcription Bivalent/Poised TSS Strong transcription Bivalent Enhancer Genic enhancers Flanking Bivalent TSS/Enh Transcr. at gene 5' and 3' ZNF genes & repeats	TF binding region CpG island Chromatin interactive region lncRNA miRNA miRNA target site	84 gene(s)	inside rSNPs	diseases
5	nsv1054147	chr15:31014507-31972706	Weak transcription Enhancers Flanking Active TSS Active TSS Strong transcription Genic enhancers Transcr. at gene 5' and 3' Bivalent Enhancer Flanking Bivalent TSS/Enh ZNF genes & repeats Bivalent/Poised TSS	TF binding region CpG island Chromatin interactive region lncRNA miRNA miRNA target site	87 gene(s)	inside rSNPs	diseases
6	nsv542306	chr15:31014507-31972706	Weak transcription Bivalent Enhancer Enhancers Flanking Active TSS Strong transcription Flanking Bivalent TSS/Enh Genic enhancers Active TSS Bivalent/Poised TSS ZNF genes & repeats Transcr. at gene 5' and 3'	TF binding region CpG island Chromatin interactive region lncRNA miRNA miRNA target site	87 gene(s)	inside rSNPs	diseases
7	nsv1036018	chr15:31140415-31544888	Enhancers Flanking Active TSS Active TSS Genic enhancers Strong transcription Weak transcription Transcr. at gene 5' and 3' Flanking Bivalent TSS/Enh Bivalent Enhancer Bivalent/Poised TSS ZNF genes & repeats	TF binding region CpG island Chromatin interactive region lncRNA miRNA miRNA target site	58 gene(s)	inside rSNPs	diseases
8	esv33507	chr15:31183324-31471023	Weak transcription Enhancers Flanking Active TSS Strong transcription ZNF genes & repeats Active TSS Bivalent Enhancer Genic enhancers Transcr. at gene 5' and 3' Bivalent/Poised TSS Flanking Bivalent TSS/Enh	TF binding region CpG island Chromatin interactive region lncRNA miRNA miRNA target site	35 gene(s)	inside rSNPs	diseases
9	nsv832952	chr15:31204426-31333998	Strong transcription Enhancers Genic enhancers Weak transcription Flanking Active TSS Active TSS ZNF genes & repeats Transcr. at gene 5' and 3' Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer	TF binding region CpG island Chromatin interactive region lncRNA miRNA target site	24 gene(s)	inside rSNPs	diseases
10	nsv1052722	chr15:31261834-31609680	Flanking Active TSS Weak transcription Enhancers Active TSS Strong transcription Bivalent Enhancer Genic enhancers Flanking Bivalent TSS/Enh Transcr. at gene 5' and 3' Bivalent/Poised TSS ZNF genes & repeats	TF binding region CpG island Chromatin interactive region lncRNA miRNA miRNA target site	52 gene(s)	inside rSNPs	diseases
11	nsv542315	chr15:31261834-31609680	Enhancers Flanking Active TSS Active TSS Bivalent Enhancer Weak transcription Genic enhancers ZNF genes & repeats Strong transcription Flanking Bivalent TSS/Enh Bivalent/Poised TSS Transcr. at gene 5' and 3'	TF binding region CpG island Chromatin interactive region lncRNA miRNA miRNA target site	52 gene(s)	inside rSNPs	diseases
12	nsv932896	chr15:31292475-31730445	Enhancers Flanking Active TSS Weak transcription Active TSS Bivalent Enhancer Genic enhancers ZNF genes & repeats Strong transcription Flanking Bivalent TSS/Enh Bivalent/Poised TSS Transcr. at gene 5' and 3'	TF binding region CpG island Chromatin interactive region lncRNA miRNA miRNA target site	59 gene(s)	inside rSNPs	diseases
13	nsv903835	chr15:31312743-31384797	Weak transcription Enhancers Flanking Active TSS Active TSS Genic enhancers Bivalent/Poised TSS Bivalent Enhancer Strong transcription Transcr. at gene 5' and 3' ZNF genes & repeats Flanking Bivalent TSS/Enh	TF binding region CpG island Chromatin interactive region lncRNA miRNA	13 gene(s)	inside rSNPs	diseases

No data

Chromatin state (count:60 , 50 per page) page: 1 2

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr15:31311000-31319600	Strong transcription	Foreskin Melanocyte Primary Cells skin01	Skin
2	chr15:31312400-31317400	Enhancers	Primary B cells from peripheral blood	blood
3	chr15:31313400-31316200	Weak transcription	Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells	embryonic stem cell
4	chr15:31313600-31316200	Enhancers	Foreskin Keratinocyte Primary Cells skin03	Skin
5	chr15:31313600-31317800	Enhancers	Breast Myoepithelial Primary Cells	Breast
6	chr15:31314400-31316200	Enhancers	HUVEC	blood vessel
7	chr15:31314600-31316200	Enhancers	Foreskin Keratinocyte Primary Cells skin02	Skin
8	chr15:31314800-31317600	Enhancers	Breast variant Human Mammary Epithelial Cells (vHMEC)	Breast
9	chr15:31314800-31318600	Enhancers	Placenta	Placenta
10	chr15:31315000-31316400	Genic enhancers	Foreskin Melanocyte Primary Cells skin03	Skin
11	chr15:31315000-31317600	Enhancers	IMR90 fetal lung fibroblasts Cell Line	lung
12	chr15:31315000-31318000	Enhancers	H1 Derived Mesenchymal Stem Cells	ES cell derived
13	chr15:31315200-31316200	Enhancers	Primary monocytes fromperipheralblood	blood
14	chr15:31315200-31316200	Enhancers	Foreskin Fibroblast Primary Cells skin01	Skin
15	chr15:31315200-31316800	Enhancers	Pancreas	Pancrea
16	chr15:31315200-31316800	Enhancers	Spleen	Spleen
17	chr15:31315200-31317200	Enhancers	Placenta Amnion	Placenta Amnion
18	chr15:31315200-31317400	Enhancers	iPS DF 6.9 Cell Line	embryonic stem cell
19	chr15:31315200-31317600	Enhancers	ES-I3 Cell Line	embryonic stem cell
20	chr15:31315200-31317600	Enhancers	Foreskin Fibroblast Primary Cells skin02	Skin
21	chr15:31315200-31317800	Enhancers	Fetal Kidney	kidney
22	chr15:31315200-31317800	Enhancers	NHLF	lung
23	chr15:31315400-31316200	Enhancers	Bone Marrow Derived Cultured Mesenchymal Stem Cells	Bone marrow
24	chr15:31315400-31316200	Enhancers	Muscle Satellite Cultured Cells	--
25	chr15:31315400-31316200	Enhancers	Hela-S3	cervix
26	chr15:31315400-31316400	Weak transcription	Fetal Muscle Leg	muscle
27	chr15:31315400-31316600	Enhancers	A549	lung
28	chr15:31315400-31316800	Enhancers	Right Atrium	heart
29	chr15:31315400-31317000	Enhancers	Adipose Nuclei	Adipose
30	chr15:31315400-31317400	Enhancers	Lung	lung
31	chr15:31315400-31317400	Enhancers	NHDF-Ad	bronchial
32	chr15:31315400-31317800	Enhancers	HUES6 Cell Line	embryonic stem cell
33	chr15:31315400-31318400	Enhancers	H1 Cell Line	embryonic stem cell
34	chr15:31315400-31318600	Enhancers	H1 BMP4 Derived Trophoblast Cultured Cells	ES cell derived
35	chr15:31315600-31316600	Weak transcription	Esophagus	oesophagus
36	chr15:31315600-31316800	Enhancers	Osteobl	bone
37	chr15:31315600-31317200	Weak transcription	Primary B cells from cord blood	blood
38	chr15:31315600-31317200	Flanking Active TSS	NHEK	skin
39	chr15:31315600-31317400	Enhancers	iPS DF 19.11 Cell Line	embryonic stem cell
40	chr15:31315600-31317400	Enhancers	Sigmoid Colon	Sigmoid Colon
41	chr15:31315600-31317600	Enhancers	H9 Cell Line	embryonic stem cell
42	chr15:31315600-31317600	Enhancers	HSMM	muscle
43	chr15:31315600-31317800	Enhancers	hESC Derived CD56+ Mesoderm Cultured Cells	ES cell derived
44	chr15:31315600-31317800	Enhancers	iPS-20b Cell Line	embryonic stem cell
45	chr15:31315600-31317800	Enhancers	NH-A	brain
46	chr15:31315600-31320400	Weak transcription	Primary Natural Killer cells fromperipheralblood	blood
47	chr15:31315800-31316600	Enhancers	HepG2	liver
48	chr15:31315800-31316600	Flanking Active TSS	HMEC	breast
49	chr15:31315800-31317400	Enhancers	H1 BMP4 Derived Mesendoderm Cultured Cells	ES cell derived
50	chr15:31315800-31317400	Enhancers	iPS-18 Cell Line	embryonic stem cell

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links